Nicotine and its withdrawal modify dorsal raphe 8-hydroxy-2-(di-n-propylamino) tetralin feeding

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 961-967

  Bishop, Christopher ^a   Parker, Graham C ^a   Coscina, Donald V ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

8 hydroxy 2 (di n propylamino) tetralin; Body weight; Dorsal raphe; Feeding; Nicotine; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; NICOTINE; SEROTONIN; SEROTONIN 1A AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEEDING; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

EID: 0037343299     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00026-1     Document Type: Article

References (39)

1. Aghajanian G.K., Wang R.Y., Baraban J. Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res. 153:1978;169-175.
2. Benwell M.E., Balfour D.J. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology (Berl.). 63:1979;7-11.
3. Bishop C., Parker G.C., Coscina D.V. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats. Psychopharmacology. 162:2002;265-272.
4. Blundell J.E. Serotonin manipulations and the structure of feeding behaviour. Appetite. 7:1986;39-56. [Suppl.].
5. Bowen D.J., Eury S.E., Grunberg N.E. Nicotine's effects on female rats' body weight: caloric intake and physical activity. Pharmacol. Biochem. Behav. 25:1986;1131-1136.
6. Currie P.J., Coscina D.V. Diurnal variations in feeding response to 8-OH-DPAT injected into the dorsal or median raphe. NeuroReport. 4:1993;1105-1107.
7. De Souza R.J., Goodwin G.M., Green A.R., Heal D.J. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists. Br. J. Pharmacol. 89:1986;377-384.
8. Deutch A.Y., Holliday J., Roth R.H., Chun L.L.Y., Hawrot E. Immunohistochemical localization of a neuronal acetylcholine receptor in mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 84:1987;8697-8701.
9. Frankish H.M., Dryden S., Wang Q., Bing C., MacFarlane I.A., Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res. 694:1995;139-146.
10. Grunberg N.E. Cigarette smoking and body weight: current perspective and future directions. Ann. Behav. Med. 11:1989;154-157.
11. Grunberg N.E., Bowen D.J., Morse D.E. Effects of nicotine on body weight and food consumption in rats. Psychopharmacology (Berl.). 83:1984;93-98.
12. Grunberg N.E., Bowen D.J., Winders S.E. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berl.). 90:1986;101-105.
13. Grunberg N.E., Winders S.E., Popp K.A. Sex differences in nicotine's effects on consummatory behavior and body weights in rats. Psychopharmacology. 91:1987;221-225.
14. 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 296:1977;91-97.
15. Hjorth S., Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;463-471.
16. Hjorth S., Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48:1991;1779-1786.
17. Hutson P.H., Dourish C.T., Curzon G. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur. J. Pharmacol. 129:1986;347-352.
18. Kane J.K., Parker S.L., Li M.D. Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neurosci. Lett. 298:2001;1-4.
19. Kennett G.A., Marcou M., Dourish C.T., Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138:1987;53-60.
20. Klesges R.C. Area review: smoking and body weight. Ann. Behav. Med. 11(4):1989;123-124.
21. Leibowitz S.F., Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry. 44:1998;851-864.
22. Levin E.D., Morgan M.M., Galvez C., Ellison G.D. Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. Physiol. Behav. 39:1987;441-444.
23. Levin E.D., Briggs S.J., Christopher N.C., Rose J.E. Sertraline attenuates hyperphagia in rats following nicotine withdrawal. Pharmacol. Biochem. Behav. 44:1993;51-61.
24. Li X., Rainnie D.G., McCarley R.W., Greene R.W. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J. Neurosci. 18:1998;1904-1912.
25. Li M.D., Kane J.K., Parker S.L., McAllen K., Matta S.G., Sharp B.M. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res. 867:2000;157-164.
26. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360:1998;31-36.
27. Miyata G., Meguid M.M., Fetissov S.O., Torelli G.F., Kim H.J. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery. 126:1999;255-263.
28. O'Hara P., Connett J.E., Lee W.W., Nides M., Murray R., Wise R. Early and late weight gain following smoking cessation in the Lung Health Study. Am. J. Epidemiol. 148:1998;821-830.
29. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, New York.
30. Rasmussen K., Czachura J.F. Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT1A agonist 8-OH-DPAT. Psychopharmacology (Berl.). 133:1997;343-346.
31. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 621:1993;311-318.
32. Samanin R., Garattini S. Serotonin and the pharmacology of eating disorders. Ann. N.Y. Acad. Sci. 575:1989;194-207.
33. Schatzberg A.F. New indications for antidepressants. J. Clin. Psychiatry. 61:2000;9-17.
34. 3H]acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42:1984;1495-1498.
35. Schwid S.R., Hirvonen M.D., Keesey R.E. Nicotine effects on body weight: a regulatory perspective. Am. J. Clin. Nutr. 55:1992;878-884.
36. Sinton C.M., Fallon S.L. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur. J. Pharmacol. 157:1988;173-181.
37. Sprouse J.S., Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1:1987;3-9.
38. Westfall T.C., Grant H., Perry H. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen. Pharmacol. 14:1983;321-325.
39. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.